Generic drug patents and exclusivity periods vary widely across countries, affecting when affordable versions of medicines become available. The U.S., EU, and other regions use different rules to balance innovation and access.
Read More
Generic drug patents and exclusivity periods vary widely across countries, affecting when affordable versions of medicines become available. The U.S., EU, and other regions use different rules to balance innovation and access.
Read More